(EMAILWIRE.COM, April 26, 2019 ) Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology with DNA analysis/profiling being a key tool in this sector. The global human identification market is expected to reach USD 1740.2 Million by 2022 from USD 928.0 Million in 2017, at a CAGR of 13.4%. Technological advancement, government initiatives for forensic programs, and focus of market players on expanding their reach are the major driving factors for this market.

The human identification market is segmented on the basis of product & service, technology, application, and end user. On the basis of product & service, the market is segmented into consumables, services, instruments, and software. The consumables segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to regular and bulk purchases of consumables coupled with product launches.

Based on technology, the global market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), capillary electrophoresis, nucleic acid isolation and purification, automated liquid handling, microarrays, and rapid DNA analysis. In 2017, the capillary electrophoresis segment accounted for the largest share of the market. Its high efficiency, faster analysis, and requirement of a small volume of solvents are driving the uptake of this technology in human identification.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100607777

By region, the human identification market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, however, the Asian region is expected to witness the highest growth during the forecast period. Asia is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. The increasing number of conferences and workshops is one of the key factors driving the market in Asia.

Thermo Fisher Scientific Inc. (US), Promega Corporation (US), QIAGEN N.V. (Netherlands), Illumina Inc. (US), and Agilent Technologies Inc. (US) are the top players in this market. These companies have a broad product portfolio with comprehensive features and a strong geographical presence.